Pfizer chasing AstraZeneca in potential $100B deal

Apr 28, 2014, 6:24 AM EDT
U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain's AstraZeneca Plc after having two bids rejected.
AFP/Getty Images

U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain's AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry.
Background:
Pfizer chasing AstraZeneca in potential $100 billion deal [Reuters]
Pfizer says it will pursue AstraZeneca [NYT]

YOU MIGHT ALSO LIKE